These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2298413)

  • 1. Flow cytometric DNA ploidy analysis of ovarian granulosa cell tumors.
    Chadha S; Cornelisse CJ; Schaberg A
    Gynecol Oncol; 1990 Feb; 36(2):240-5. PubMed ID: 2298413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy of ovarian granulosa cell tumors. Lack of correlation between DNA index or proliferative index and outcome in 40 patients.
    Evans MP; Webb MJ; Gaffey TA; Katzmann JA; Suman VJ; Hu TC
    Cancer; 1995 May; 75(9):2295-8. PubMed ID: 7712440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary.
    Klemi PJ; Joensuu H; Salmi T
    Cancer; 1990 Mar; 65(5):1189-93. PubMed ID: 2302667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulosa cell tumor of ovary: a clinicopathologic and flow cytometric DNA analysis.
    Roush GR; el-Naggar AK; Abdul-Karim FW
    Gynecol Oncol; 1995 Mar; 56(3):430-4. PubMed ID: 7705680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulosa cell tumor of the ovary. Histopathologic and flow cytometric analysis with clinical correlation.
    Suh KS; Silverberg SG; Rhame JG; Wilkinson DS
    Arch Pathol Lab Med; 1990 May; 114(5):496-501. PubMed ID: 2334259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of granulosa tumors.
    Hitchcock CL; Norris HJ; Khalifa MA; Wargotz ES
    Cancer; 1989 Nov; 64(10):2127-32. PubMed ID: 2804901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of cellular DNA content in ovarian cancer.
    Hamaguchi K; Nishimura H; Miyoshi T; Miyahara K; Tateno N; Yakushiji M; Yokoyama MM
    Gynecol Oncol; 1990 May; 37(2):219-23. PubMed ID: 2344967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analysis of flow cytometry and morphometry of ovarian granulosa cell tumor.
    Haba R; Miki H; Kobayashi S; Ohmori M
    Cancer; 1993 Dec; 72(11):3258-62. PubMed ID: 8242551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian granulosa-stromal cell tumors are characterized by trisomy 12.
    Fletcher JA; Gibas Z; Donovan K; Perez-Atayde A; Genest D; Morton CC; Lage JM
    Am J Pathol; 1991 Mar; 138(3):515-20. PubMed ID: 2000932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of DNA and cell proliferation in ovarian tumors.
    Christov K; Vassilev N
    Cancer; 1988 Jan; 61(1):121-5. PubMed ID: 3334938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry of ovarian granulosa cell tumours. The value of tissue specific proteins and tumour markers.
    Chadha S; van der Kwast TH
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(5):439-45. PubMed ID: 2471350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma.
    Kaern J; Tropé CG; Kristensen GB; Pettersen EO
    Cancer; 1994 Apr; 73(7):1870-7. PubMed ID: 8137213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value.
    Costa MJ; DeRose PB; Roth LM; Brescia RJ; Zaloudek CJ; Cohen C
    Hum Pathol; 1994 Jan; 25(1):60-6. PubMed ID: 8314261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
    Lage JM; Weinberg DS; Huettner PC; Mark SD
    Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA content in juvenile granulosa cell tumors of the ovary: a study of early- and advanced-stage disease.
    Jacoby AF; Young RH; Colvin RB; Flotte TJ; Preffer F; Scully RE; Swymer CM; Bell DA
    Gynecol Oncol; 1992 Jul; 46(1):97-103. PubMed ID: 1634146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
    Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
    Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
    Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.